Rankings
▼
Calendar
KNSA FY 2016 Earnings — Kiniksa Pharmaceuticals, Ltd. Revenue & Financial Results | Market Cap Arena
KNSA
Kiniksa Pharmaceuticals, Ltd.
$3B
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$22,000
Operating Income
-$24M
Net Income
-$24M
EPS (Diluted)
$-0.74
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$368,000
Balance Sheet
Total Assets
$56M
Total Liabilities
$82M
Stockholders' Equity
-$26M
Cash & Equivalents
$56M
← Q1 2017
All Quarters
